Late relapse following autologous bone marrow transplantation for acute myelogenous leukemia: case report and review of the literature.
Most relapses following autologous bone marrow transplantation (BMT) for acute myelogenous leukemia (AML) occur within 18 months. A patient is presented who relapsed 4 years after successful autologous BMT for AML. A review of the literature confirms this to be a rare event and may have been associated with extramedullary relapse of the leukemia.
Dann
E J
EJ
Department of Hematology, Hadassah University Hospital, Jerusalem, Israel.
Gillis
S
S
Rowe
J M
JM
D000328:Adult; D016026:Bone Marrow Transplantation; D005500:Follow-Up Studies; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D012008:Recurrence; D013997:Time Factors; D014182:Transplantation, Autologous